9594
Riyadh - Mubasher: Al Modawat Specialized Medical Company signed an engagement letter with Deloitte & Touche to conduct financial due diligence as part of its efforts to transfer shares from the Parallel Market (Nomu) to the Main Market (TASI).
The process is subject to fulfilling all applicable requirements and obtaining approvals from the relevant authorities, according to a bourse filing.
The announcement follows Al Mawada’s board decision, disclosed on 2 June 2025, to pursue a move from Nomu to TASI.
During the first quarter (Q1) of 2026, the total revenues of Al Modawat reached SAR 34.90 million, marking a 21.71% year-on-year (YoY) surge from SAR 28.67 million.